These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 27252420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL, Kim D, Jang EJ, Lee MY, Song HJ, Park SY, Cho SK, Sung YK, Choi CB, Won S, Bang SY, Cha HS, Choe JY, Chung WT, Hong SJ, Jun JB, Kim J, Kim SK, Kim TH, Kim TJ, Koh E, Lee H, Lee HS, Lee J, Lee SS, Lee SW, Park SH, Shim SC, Yoo DH, Yoon BY, Bae SC, Lee EK.
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [Abstract] [Full Text] [Related]

  • 3. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.
    Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Ma M, Walker D, Heslin M, Patel A, Kingsley G.
    Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data.
    Kievit W, Adang EM, Fransen J, Kuper HH, van de Laar MA, Jansen TL, De Gendt CM, De Rooij DJ, Brus HL, Van Oijen PC, Van Riel PC.
    Ann Rheum Dis; 2008 Sep; 67(9):1229-34. PubMed ID: 18174220
    [Abstract] [Full Text] [Related]

  • 7. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
    Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML.
    J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
    Carreño A, Fernández I, Badia X, Varela C, Roset M.
    Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F, Costs and Quality of Life in Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2006 Oct 15; 55(5):751-6. PubMed ID: 17013822
    [Abstract] [Full Text] [Related]

  • 12. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA.
    Arthritis Care Res (Hoboken); 2012 Jun 15; 64(6):826-32. PubMed ID: 22262513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
    Bechman K, Tweehuysen L, Garrood T, Scott DL, Cope AP, Galloway JB, Ma MHY.
    J Rheumatol; 2018 Nov 15; 45(11):1515-1521. PubMed ID: 30173149
    [Abstract] [Full Text] [Related]

  • 15. Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.
    Lindgren P, Geborek P, Kobelt G.
    Int J Technol Assess Health Care; 2009 Apr 15; 25(2):181-9. PubMed ID: 19331709
    [Abstract] [Full Text] [Related]

  • 16. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A.
    Semin Arthritis Rheum; 2011 Aug 15; 41(1):81-9. PubMed ID: 21168187
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary].
    Péntek M, Szekanecz Z, Czirják L, Poór G, Rojkovich B, Polgár A, Genti G, Kiss CG, Sándor Z, Májer I, Brodszky V, Gulácsi L.
    Orv Hetil; 2008 Apr 20; 149(16):733-41. PubMed ID: 18426720
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hospital Anxiety and Depression Scale Score Is an Independent Factor Associated With the EuroQoL 5-Dimensional Descriptive System in Patients With Rheumatoid Arthritis.
    Hattori Y, Katayama M, Kida D, Kaneko A.
    J Clin Rheumatol; 2018 Sep 20; 24(6):308-312. PubMed ID: 29742541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.